跳至主要内容
临床试验/NCT01551563
NCT01551563招募中不适用

Management of Inflammatory Bowel Disease in the Stavanger Area - a Prospective Evaluation of Standardized Treatment Regimens on Disease Outcome With Focus on Mucosal Healing and Associations to Fatigue

Helse Stavanger HF1 个研究点 分布在 1 个国家目标入组 700 人开始时间: 2012年4月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
700
试验地点
1
主要终点
Clinical efficacy of IBD drug therapy

研究概览

简要总结

The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined.

Cytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.

详细描述

none considered needed

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
16 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • newly diagnosed IBD

排除标准

  • previous IBD with specific treatment within 10 year
  • inability to consent
  • inability to adhere to treatment protocol

结局指标

主要结局

Clinical efficacy of IBD drug therapy

时间窗: 5 years

Endoscopic, clinical and biochemical response

次要结局

  • Fatigue in patients with coeliac disease - substudy(1 year)
  • Fatigue in IBD(5 years)
  • IBD and the intestinal microbiome(5 years)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验